Saturday 17 October 2026
Export XCUR’s income statement to Excel — free account
Exicure, Inc.
XCUR Healthcare Biotechnology
Exicure, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $500,000.00, down 98.3% from fiscal 2022. In the quarter to June 2026, EPS grew 56.1% and free cash flow grew 65.4%, each against the same quarter a year earlier.
1.11
0.01
−0.89%
Follow XCUR
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 3 | 5 | 3 | — | — |
P/E ratio |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.22 |
Altman Z-Score |
— | (18.31) | — | (8.57) | (6.48) | 1.10 | 1.98 | 7.09 | — | — |
P/S ratio |
— | 1.04 | — | 0.22 | 0.00 | 9.28 | 127.14 | 1,234.35 | 16.64 | 16.64 |
P/FCF ratio |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 701.19 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (43.13) | — | (20.43) | (13.84) | 1.26 | 3.25 | (2.67) | 1.63 | (6.20) |
P/Operating CF |
— | (33.05) | — | (0.87) | (1.30) | (13.06) | 10.75 | (24.43) | (26.23) | (26.23) |
Beneish M-Score |
— | — | — | — | — | 19.50 | 6.29 | (12.70) | 6.01 | — |
P/B ratio |
— | 4.12 | — | 0.42 | 1.59 | 2.51 | 2.04 | 6.95 | 7.47 | 7.47 |
Price to Tangible BV |
— | 4.12 | — | 0.42 | 1.59 | 2.51 | 2.04 | 6.95 | 7.47 | 7.47 |
EV/Sales |
— | 0.85 | — | 0.18 | 14.42 | 5.35 | 45.54 | 1,095.22 | 14.42 | 14.42 |
EV/EBITDA |
— | 0.00 | — | 10.11 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (7.85) | — | (0.14) | 0.20 | (2.26) | 44.81 | (6.63) | (6.06) | (6.06) |
EV/FCF |
— | (11.49) | — | (0.14) | 0.19 | (2.10) | 251.14 | (6.53) | (5.75) | (5.75) |
Quick Ratio |
0.98 | 4.24 | 0.33 | 5.23 | 1.15 | 5.98 | 3.56 | 12.86 | 7.69 | 1.62 |
Current Ratio |
1.19 | 4.45 | 0.81 | 6.13 | 1.28 | 6.29 | 3.63 | 13.54 | 8.24 | 1.65 |
Net Debt/EBITDA |
0.99 | 1.10 | 0.06 | (17.15) | 0.54 | 2.77 | 4.11 | 1.00 | 2.09 | 0.88 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 10.60% | 16.74% | 4.36% | 17.13% | 16.75% | 27.54% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.61 | 0.27 | 0.06 | 0.24 | 0.24 | 2.32 |
Asset Turnover |
0.00 | 0.04 | 0.00 | 0.65 | (0.01) | 0.15 | 0.02 | 0.00 | 0.39 | 0.04 |
Operating CF/Net income |
1.73 | 0.30 | 0.61 | 13.81 | 0.54 | 1.59 | (0.05) | 0.87 | 1.80 | 0.30 |
Capex/Depreciation |
0.09 | 0.00 | 0.67 | 0.08 | (0.43) | (1.69) | (1.19) | (0.21) | (2.20) | (1.06) |
Interest Coverage |
(4,233.00) | (679.56) | — | (3.08) | (36.99) | (44.39) | (33.86) | (32.47) | (13.09) | (22.32) |
| (92.47%) | (197.92%) | (188.43%) | (19.74%) | (176.25%) | (34.68%) | (51.73%) | (109.53%) | 108.98% | 167.67% | |
| (34.00%) | (72.84%) | (96.91%) | (5.86%) | (77.55%) | (22.87%) | (36.53%) | (77.63%) | (44.43%) | (68.36%) | |
ROIC |
(1,469.79%) | 0.00% | (423.14%) | (18.04%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(474.66%) | (91.28%) | 3,915.28% | (23.60%) | (473.92%) | (32.16%) | (31.39%) | (84.00%) | (43.01%) | (202.02%) |
Average Days of Receivables |
0.00 | 380.33 | 0.00 | 0.00 | 0.00 | 0.24 | 9.86 | 9.28 | 1.13 | 5.28 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 68.57% | (10,140.58%) | 193.19% | 1,492.28% | 11,965.25% | 134.58% | 1,318.44% |
Selling, General and Administrative Expense of Revenue |
0.00% | 1,089.80% | 0.00% | 37.78% | (2,709.52%) | 59.92% | 661.50% | 6,625.42% | 72.50% | 341.60% |
Intangible Assets out of Total Assets |
0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 4.40% | 0.00% | 4.75% | (608.49%) | 13.15% | 141.98% | 1,533.05% | 15.04% | 65.83% |
Graham Net Nets |
— | 0.19 | — | 0.26 | (0.56) | 0.31 | 0.47 | 0.14 | 0.12 | 0.12 |
Graham Number |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (35.19%) | — | (51.26%) | (356.80%) | (16.40%) | (16.07%) | (15.39%) | 464.08% | 464.08% |
Free Cash Flow Yield |
— | (7.12%) | — | (560.41%) | (199.91%) | (27.52%) | 0.14% | (13.58%) | (15.07%) | (15.07%) |
Revenue per Share |
0.00 | 0.24 | 0.00 | 31.20 | (0.82) | 28.60 | 3.37 | 0.43 | 144.20 | 1,295.00 |
Operating CF per Share |
(1.36) | (1.42) | (6.46) | (38.60) | (58.94) | (67.61) | 3.43 | (71.04) | (293.61) | (6,312.50) |
Capex per Share |
0.01 | 0.00 | 0.58 | 0.21 | (1.64) | (5.46) | (2.82) | (0.34) | (13.74) | (492.50) |
Free Cash Flow per Share |
(1.35) | (1.42) | (5.89) | (38.39) | (60.57) | (73.07) | 0.61 | (71.39) | (307.34) | (6,805.00) |
Cash per Share |
0.59 | 6.12 | 0.51 | 9.28 | 66.25 | 141.32 | 288.43 | 95.76 | 382.26 | 24,528.75 |
Shareholders Equity per Share |
0.62 | 3.31 | 1.89 | 16.15 | 19.01 | 105.90 | 210.22 | 76.38 | 296.37 | 3,060.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Book value per Share |
0.62 | 3.31 | 1.89 | 16.15 | 19.01 | 105.90 | 210.22 | 76.38 | 296.37 | 3,060.00 |
Free Cash Flow |
(8.51) | (2.91) | (9.43) | (35.46) | (35.79) | (42.44) | 0.24 | (19.58) | (20.71) | (5.44) |
Working Capital |
0.74 | 10.60 | (0.49) | 8.41 | 9.60 | 72.59 | 81.69 | 25.62 | 24.28 | 7.88 |
Capital Expenditures |
0.04 | — | 0.92 | 0.20 | (0.97) | (3.17) | (1.08) | (0.09) | (0.93) | (0.39) |
Net Current Asset Value |
(5.49) | 5.39 | (6.52) | 1.65 | (9.97) | 47.38 | 78.26 | 19.86 | 18.63 | 1.91 |
EV/EBIT |
— | 0.00 | — | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.00 | (0.01) | (2.00) | 0.19 | 0.83 | 0.80 | 0.10 | 0.38 |
Price to Operating Income |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.50 | 31.69 | 25.46 | 0.92 | 0.57 | 0.46 | 0.44 | 0.43 | 0.32 | 0.74 |
Cash ROIC |
(110.97%) | (15.09%) | (245.26%) | (150.91%) | (62.51%) | (26.46%) | 0.12% | (37.55%) | (40.94%) | (19.63%) |
Accounts Receivable Turnover |
0.00 | 1.87 | 0.00 | 0.00 | 0.00 | 722.30 | 68.21 | 7.15 | 431.96 | 46.04 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
0.29 | 0.27 | 0.01 | — | — | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Average Payables |
1.36 | 1.33 | 1.00 | 1.89 | 2.64 | 1.84 | 1.16 | 0.77 | 0.78 | 0.78 |
Average Assets |
14.55 | 13.32 | 17.45 | 44.10 | 82.66 | 107.85 | 72.01 | 28.87 | 24.78 | 24.78 |
Average Common Equity |
5.35 | 4.90 | 8.98 | 13.08 | 36.37 | 71.13 | 50.85 | 20.46 | (10.10) | (10.10) |
Columns are period end dates